{
  "signal_id": "repurpose-compound-ax-17-example-osteoarthritis-01",
  "compound": "Compound AX-17 (example)",
  "proposed_species": [
    "canine"
  ],
  "proposed_condition": "Osteoarthritis",
  "summary_hypothesis": "Research hypothesis: Compound AX-17 (example) may warrant evaluation for Osteoarthritis in canine.",
  "why_failed_originally": {
    "summary": "Primary endpoint did not reach statistical significance in target population. Enrollment skewed toward late-stage disease, limiting responsiveness.",
    "failure_type": "efficacy",
    "key_points": [
      "Primary endpoint did not reach statistical significance in target population.",
      "Enrollment skewed toward late-stage disease, limiting responsiveness."
    ]
  },
  "why_it_might_work_in_animals": {
    "summary": "Canine inflammatory response may be more responsive to short-term modulation.",
    "key_points": [
      "Canine inflammatory response may be more responsive to short-term modulation."
    ]
  },
  "evidence": {
    "vet_strength": "weak",
    "key_docs": [
      "pmid:EXAMPLE-VET-101",
      "ctgov:EXAMPLE-OA-001"
    ],
    "notes": "Evidence is research-only and requires validation."
  },
  "risk": {
    "overall_risk": 35,
    "key_flags": [
      "GI intolerance risk (severity 2)"
    ]
  },
  "novelty_vectors": [
    "new_species",
    "new_indication"
  ],
  "confidence_score": 28,
  "addressability_score": 70,
  "translation_risk": 30,
  "score_breakdown": {
    "vet_evidence": 12,
    "species_rationale": 14,
    "addressability": 14,
    "recency_volume": 2,
    "risk_penalty": 14
  },
  "recommended_next_steps": [
    "retrospective_review",
    "in_vitro",
    "pilot_study"
  ],
  "provenance": {
    "agent_run_ids": [
      "repurpose-2026-02-07T23-13-17-120Z"
    ],
    "timestamps": [
      "2026-02-07T23:13:17.122Z"
    ]
  },
  "reasoning_summaries": {
    "executive_summary": [
      "Compound AX-17 (example): Primary endpoint did not reach statistical significance in target population. Enrollment skewed toward late-stage disease, limiting responsiveness.",
      "Canine inflammatory response may be more responsive to short-term modulation.",
      "Veterinary evidence is weak with 1 cited item(s). Evidence remains limited.",
      "Risk profile is moderate (35/100) with flagged contraindications requiring review."
    ],
    "failure_summary": "Primary endpoint did not reach statistical significance in target population. Enrollment skewed toward late-stage disease, limiting responsiveness. Failure type: efficacy.",
    "species_benefit_summary": [
      {
        "species": "canine",
        "summary": "Canine inflammatory response may be more responsive to short-term modulation."
      }
    ],
    "evidence_summary": "Veterinary evidence is weak with 1 cited item(s). Evidence remains limited.",
    "risk_summary": "Risk profile is moderate (35/100) with flagged contraindications requiring review.",
    "next_steps_summary": "Next steps: retrospective_review, in_vitro, pilot_study (research-only)."
  },
  "disclaimer": "Research hypothesis only; not medical advice."
}